CN109467538A - 环烯烃取代的杂芳环类化合物及其用途 - Google Patents
环烯烃取代的杂芳环类化合物及其用途 Download PDFInfo
- Publication number
- CN109467538A CN109467538A CN201710801364.3A CN201710801364A CN109467538A CN 109467538 A CN109467538 A CN 109467538A CN 201710801364 A CN201710801364 A CN 201710801364A CN 109467538 A CN109467538 A CN 109467538A
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- alkyl
- halogen
- solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
- C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Priority Applications (29)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710801364.3A CN109467538A (zh) | 2017-09-07 | 2017-09-07 | 环烯烃取代的杂芳环类化合物及其用途 |
| CN202311036787.2A CN116999441B (zh) | 2017-09-07 | 2018-09-07 | 环烯烃取代的杂芳环类化合物及其用途 |
| MX2020002505A MX2020002505A (es) | 2017-09-07 | 2018-09-07 | Compuestos heteroaromaticos sustituidos con cicloolefinas y su uso. |
| CN202311040510.7A CN117024363A (zh) | 2017-09-07 | 2018-09-07 | 环烯烃取代的杂芳环类化合物及其用途 |
| ARP180102548A AR112794A1 (es) | 2017-09-07 | 2018-09-07 | Compuestos heteroaromáticos sustituidos con cicloolefinas y su uso en el tratamiento de enfermedades inducidas por mutaciones idh |
| JP2020513872A JP7273030B6 (ja) | 2017-09-07 | 2018-09-07 | シクロオレフィン置換複素芳香族化合物およびそれらの使用 |
| SG11202001642WA SG11202001642WA (en) | 2017-09-07 | 2018-09-07 | Cycloolefin substituted heteroaromatic compounds and their use |
| EP18853366.5A EP3679020A4 (en) | 2017-09-07 | 2018-09-07 | CYCLOOLEFIN SUBSTITUTED HETEROAROMATIC COMPOUNDS AND THEIR USES |
| CN201880057118.4A CN111132967B (zh) | 2017-09-07 | 2018-09-07 | 环烯烃取代的杂芳环类化合物及其用途 |
| US16/645,329 US11414390B2 (en) | 2017-09-07 | 2018-09-07 | Cycloolefin substituted heteroaromatic compounds and their use |
| EA202090653A EA202090653A1 (ru) | 2017-09-07 | 2018-09-07 | Циклоолефиновые замещённые гетероароматические соединения и их применение |
| CA3073782A CA3073782A1 (en) | 2017-09-07 | 2018-09-07 | Cycloolefin substituted heteroaromatic compounds and their use |
| PE2020000280A PE20200727A1 (es) | 2017-09-07 | 2018-09-07 | Compuestos heteroaromaticos sustituidos con cicloolefinas y su uso |
| BR112020004563-2A BR112020004563B1 (pt) | 2017-09-07 | 2018-09-07 | Compostos heteroaromáticos substituídos por ciclo-olefina e seu uso |
| CN202311036845.1A CN117257809B (zh) | 2017-09-07 | 2018-09-07 | 环烯烃取代的杂芳环类化合物及其用途 |
| UAA202002089A UA129118C2 (uk) | 2017-09-07 | 2018-09-07 | Циклоолефінозаміщені гетероароматичні сполуки та їх використання |
| KR1020207009621A KR102566237B1 (ko) | 2017-09-07 | 2018-09-07 | 사이클로올레핀 치환된 헤테로방향족 화합물 및 그의 용도 |
| CN202311036829.2A CN117797156A (zh) | 2017-09-07 | 2018-09-07 | 环烯烃取代的杂芳环类化合物及其用途 |
| PCT/CN2018/104531 WO2019047909A1 (en) | 2017-09-07 | 2018-09-07 | HETEROAROMATIC COMPOUNDS SUBSTITUTED WITH CYCLOOLEFINS AND THEIR USE |
| AU2018329047A AU2018329047B2 (en) | 2017-09-07 | 2018-09-07 | Cycloolefin substituted heteroaromatic compounds and their use |
| TW107131525A TWI816693B (zh) | 2017-09-07 | 2018-09-07 | 環烯烴取代的雜芳環類化合物及其用途 |
| NZ762447A NZ762447B2 (en) | 2018-09-07 | Cycloolefin substituted heteroaromatic compounds and their use | |
| IL272923A IL272923B2 (en) | 2017-09-07 | 2020-02-26 | Disubstituted cycloolefin heteroaromatic compounds and their uses |
| PH12020500408A PH12020500408A1 (en) | 2017-09-07 | 2020-02-28 | Cycloolefin substituted heteroaromatic compounds and their use |
| CL2020000553A CL2020000553A1 (es) | 2017-09-07 | 2020-03-05 | Compuestos heteroaromáticos sustituidos con cicloolefinas y su uso. |
| ZA2020/01448A ZA202001448B (en) | 2017-09-07 | 2020-03-06 | Cycloolefin substituted heteroaromatic compounds and their use |
| US17/747,925 US12234211B2 (en) | 2017-09-07 | 2022-05-18 | Cycloolefin substituted heteroaromatic compounds and their use |
| JP2023072737A JP7603740B2 (ja) | 2017-09-07 | 2023-04-26 | シクロオレフィン置換複素芳香族化合物およびそれらの使用 |
| US19/050,772 US20250223267A1 (en) | 2017-09-07 | 2025-02-11 | Cycloolefin substituted heteroaromatic compounds and their use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710801364.3A CN109467538A (zh) | 2017-09-07 | 2017-09-07 | 环烯烃取代的杂芳环类化合物及其用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109467538A true CN109467538A (zh) | 2019-03-15 |
Family
ID=65634832
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710801364.3A Pending CN109467538A (zh) | 2017-09-07 | 2017-09-07 | 环烯烃取代的杂芳环类化合物及其用途 |
| CN202311040510.7A Pending CN117024363A (zh) | 2017-09-07 | 2018-09-07 | 环烯烃取代的杂芳环类化合物及其用途 |
| CN202311036845.1A Active CN117257809B (zh) | 2017-09-07 | 2018-09-07 | 环烯烃取代的杂芳环类化合物及其用途 |
| CN201880057118.4A Active CN111132967B (zh) | 2017-09-07 | 2018-09-07 | 环烯烃取代的杂芳环类化合物及其用途 |
| CN202311036787.2A Active CN116999441B (zh) | 2017-09-07 | 2018-09-07 | 环烯烃取代的杂芳环类化合物及其用途 |
| CN202311036829.2A Pending CN117797156A (zh) | 2017-09-07 | 2018-09-07 | 环烯烃取代的杂芳环类化合物及其用途 |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311040510.7A Pending CN117024363A (zh) | 2017-09-07 | 2018-09-07 | 环烯烃取代的杂芳环类化合物及其用途 |
| CN202311036845.1A Active CN117257809B (zh) | 2017-09-07 | 2018-09-07 | 环烯烃取代的杂芳环类化合物及其用途 |
| CN201880057118.4A Active CN111132967B (zh) | 2017-09-07 | 2018-09-07 | 环烯烃取代的杂芳环类化合物及其用途 |
| CN202311036787.2A Active CN116999441B (zh) | 2017-09-07 | 2018-09-07 | 环烯烃取代的杂芳环类化合物及其用途 |
| CN202311036829.2A Pending CN117797156A (zh) | 2017-09-07 | 2018-09-07 | 环烯烃取代的杂芳环类化合物及其用途 |
Country Status (19)
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111132967A (zh) * | 2017-09-07 | 2020-05-08 | 和记黄埔医药(上海)有限公司 | 环烯烃取代的杂芳环类化合物及其用途 |
| WO2022095756A1 (zh) * | 2020-11-09 | 2022-05-12 | 贝达药业股份有限公司 | 突变型idh1和idh2抑制剂及其应用 |
| WO2023134686A1 (zh) * | 2022-01-11 | 2023-07-20 | 正大天晴药业集团股份有限公司 | 一种1,3,5-三嗪衍生物的制备方法 |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3678666B1 (en) | 2017-09-07 | 2025-07-09 | Augusta University Research Institute, Inc. | Specific akt3 activator and uses thereof |
| WO2026026904A1 (en) * | 2024-08-01 | 2026-02-05 | Hutchmed Limited | The crystalline forms of a compound |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3555154A (en) * | 1967-08-16 | 1971-01-12 | Armour Pharma | Preparations containing 6 - cycloalkylguanamines and methods for treating inflammatory conditions therewith |
| EP0361489A3 (en) | 1988-09-30 | 1991-06-12 | Chugai Seiyaku Kabushiki Kaisha | Novel 3,4-diaminoquinoline and pyridine compounds |
| MXPA02003436A (es) | 1999-10-07 | 2002-08-20 | Amgen Inc | Inhibidores de triazina cinasa. |
| TWI259081B (en) * | 2001-10-26 | 2006-08-01 | Sugen Inc | Treatment of acute myeloid leukemia with indolinone compounds |
| US7467603B2 (en) | 2004-05-24 | 2008-12-23 | Equusys, Incorporated | Animal instrumentation |
| GB0512324D0 (en) | 2005-06-16 | 2005-07-27 | Novartis Ag | Organic compounds |
| CA2648804C (en) | 2006-04-07 | 2014-05-27 | Methylgene Inc. | Benzamide derivatives as inhibitors of histone deacetylase |
| EP2066645A2 (en) | 2006-09-12 | 2009-06-10 | UCB Pharma S.A. | 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions |
| WO2008122378A1 (en) * | 2007-04-04 | 2008-10-16 | Ucb Pharma, S.A. | Novel pyridine derivatives, processes for preparing them, pharmaceutical compositions thereof |
| JO3240B1 (ar) | 2007-10-17 | 2018-03-08 | Janssen Pharmaceutica Nv | c-fms مثبطات كيناز |
| AU2008345225A1 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| CN102625799A (zh) | 2009-06-25 | 2012-08-01 | 安姆根有限公司 | 杂环化合物及其用途 |
| WO2011078143A1 (ja) | 2009-12-22 | 2011-06-30 | 塩野義製薬株式会社 | ピリミジン誘導体およびそれらを含有する医薬組成物 |
| EP2588471A1 (en) | 2010-06-30 | 2013-05-08 | Amgen Inc. | Heterocyclic compounds and their use as inhibitors of pi3k activity |
| WO2012117048A1 (en) | 2011-03-02 | 2012-09-07 | Lead Discovery Center Gmbh | Pharmaceutically active disubstituted triazine derivatives |
| HRP20171554T1 (hr) | 2011-09-12 | 2017-11-17 | Merck Patent Gmbh | Novi imidazol amini kao modulatori aktivnosti kinaze |
| ES2646759T3 (es) | 2011-09-12 | 2017-12-15 | Merck Patent Gmbh | Derivados de aminopirimidina para uso como moduladores de la actividad de la quinasa |
| MX342326B (es) | 2011-09-27 | 2016-09-26 | Novartis Ag | 3-pirimidin-4-il-oxazolidin-2-onas como inhibidoras de idh mutante. |
| SMT201800334T1 (it) | 2012-01-06 | 2018-09-13 | Agios Pharmaceuticals Inc | Composti terapeuticamente attivi e loro metodi di utilizzo |
| JP6479667B2 (ja) * | 2012-10-24 | 2019-03-06 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | 除草性アジン |
| CN103044469A (zh) | 2012-11-30 | 2013-04-17 | 大连联化化学有限公司 | 一种制备环戊烯/环己烯-1-硼酸频哪醇酯的方法 |
| US9862692B2 (en) | 2013-01-23 | 2018-01-09 | The University Of Toledo | Highly selective anti-cancer agents targeting non-small cell lung cancer and other forms of cancer |
| CN105593215B (zh) | 2013-07-11 | 2019-01-15 | 安吉奥斯医药品有限公司 | 用于治疗癌症的作为idh2突变体抑制剂的2,4-或4,6-二氨基嘧啶化合物 |
| WO2015003360A2 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| WO2015003355A2 (en) * | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| MX375030B (es) * | 2013-07-11 | 2025-03-06 | Agios Pharmaceuticals Inc | Compuestos de n,6-bis(aril o heteroaril)-1,3,5-triazin-2,4-diamina como inhibidores de idh2 mutantes para el tratamiento de cancer. |
| CN105916507A (zh) | 2013-08-02 | 2016-08-31 | 安吉奥斯医药品有限公司 | 治疗活性化合物及其使用方法 |
| DK3063143T3 (en) | 2013-11-01 | 2018-08-20 | Novartis Ag | Amino heteroaryl benzamides as kinase inhibitors |
| WO2015187088A1 (en) | 2014-06-04 | 2015-12-10 | Thomas Helledays Stiftelse För Medicinsk Forskning | Mth1 inhibitors for treatment of cancer |
| CN106794181A (zh) | 2014-06-04 | 2017-05-31 | 托马斯·黑勒戴药物研究基金会 | 用于治疗炎性和自身免疫性病况的mth1抑制剂 |
| KR102526632B1 (ko) * | 2014-11-19 | 2023-04-27 | 엔제트피 유케이 리미티드 | 스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 5β-6-알킬-7-하이드록시-3-온 스테로이드 |
| WO2016119707A1 (en) * | 2015-01-29 | 2016-08-04 | Hutchison Medipharma Limited | Novel heteroaryl and heterocycle compounds, compositions and methods |
| AU2016299092B2 (en) | 2015-07-30 | 2020-08-20 | Centaurus Biopharma Co., Ltd. | 1, 3, 5-triazine derivative and method of using same |
| WO2017059280A1 (en) | 2015-10-02 | 2017-04-06 | The University Of North Carolina At Chapel Hill | Novel pan-tam inhibitors and mer/axl dual inhibitors |
| MA43374A (fr) | 2015-12-04 | 2018-10-10 | Agios Pharmaceuticals Inc | Méthodes de traitement de tumeurs malignes |
| WO2017096945A1 (zh) | 2015-12-07 | 2017-06-15 | 北京康美特科技股份有限公司 | 含硼有机硅化合物、太阳能电池组件用密封剂以及太阳能电池组件 |
| IL307931A (en) | 2016-04-15 | 2023-12-01 | Epizyme Inc | Amine-substituted aryl or heteroaryl compounds as ehmt1 and ehmt2 inhibitors |
| CN107382840B (zh) | 2016-05-16 | 2020-09-01 | 四川大学 | 吡啶类化合物及其作为idh功能变异突变体抑制剂类药物的用途 |
| CR20200124A (es) | 2017-08-15 | 2020-09-28 | Abbvie Inc | Inhibidores macrocíclicos de mcl-1 y métodos de uso |
| CN109467538A (zh) * | 2017-09-07 | 2019-03-15 | 和记黄埔医药(上海)有限公司 | 环烯烃取代的杂芳环类化合物及其用途 |
| TWI707859B (zh) | 2017-09-07 | 2020-10-21 | 日商衛材R&D企管股份有限公司 | 五環化合物 |
-
2017
- 2017-09-07 CN CN201710801364.3A patent/CN109467538A/zh active Pending
-
2018
- 2018-09-07 PE PE2020000280A patent/PE20200727A1/es unknown
- 2018-09-07 EP EP18853366.5A patent/EP3679020A4/en active Pending
- 2018-09-07 US US16/645,329 patent/US11414390B2/en active Active
- 2018-09-07 CA CA3073782A patent/CA3073782A1/en active Pending
- 2018-09-07 KR KR1020207009621A patent/KR102566237B1/ko active Active
- 2018-09-07 CN CN202311040510.7A patent/CN117024363A/zh active Pending
- 2018-09-07 CN CN202311036845.1A patent/CN117257809B/zh active Active
- 2018-09-07 CN CN201880057118.4A patent/CN111132967B/zh active Active
- 2018-09-07 AU AU2018329047A patent/AU2018329047B2/en active Active
- 2018-09-07 MX MX2020002505A patent/MX2020002505A/es unknown
- 2018-09-07 CN CN202311036787.2A patent/CN116999441B/zh active Active
- 2018-09-07 SG SG11202001642WA patent/SG11202001642WA/en unknown
- 2018-09-07 UA UAA202002089A patent/UA129118C2/uk unknown
- 2018-09-07 CN CN202311036829.2A patent/CN117797156A/zh active Pending
- 2018-09-07 JP JP2020513872A patent/JP7273030B6/ja active Active
- 2018-09-07 WO PCT/CN2018/104531 patent/WO2019047909A1/en not_active Ceased
- 2018-09-07 EA EA202090653A patent/EA202090653A1/ru unknown
- 2018-09-07 AR ARP180102548A patent/AR112794A1/es active IP Right Grant
- 2018-09-07 TW TW107131525A patent/TWI816693B/zh active
-
2020
- 2020-02-26 IL IL272923A patent/IL272923B2/en unknown
- 2020-02-28 PH PH12020500408A patent/PH12020500408A1/en unknown
- 2020-03-05 CL CL2020000553A patent/CL2020000553A1/es unknown
- 2020-03-06 ZA ZA2020/01448A patent/ZA202001448B/en unknown
-
2022
- 2022-05-18 US US17/747,925 patent/US12234211B2/en active Active
-
2023
- 2023-04-26 JP JP2023072737A patent/JP7603740B2/ja active Active
-
2025
- 2025-02-11 US US19/050,772 patent/US20250223267A1/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111132967A (zh) * | 2017-09-07 | 2020-05-08 | 和记黄埔医药(上海)有限公司 | 环烯烃取代的杂芳环类化合物及其用途 |
| CN111132967B (zh) * | 2017-09-07 | 2023-08-04 | 和记黄埔医药(上海)有限公司 | 环烯烃取代的杂芳环类化合物及其用途 |
| WO2022095756A1 (zh) * | 2020-11-09 | 2022-05-12 | 贝达药业股份有限公司 | 突变型idh1和idh2抑制剂及其应用 |
| CN116209655A (zh) * | 2020-11-09 | 2023-06-02 | 贝达药业股份有限公司 | 突变型idh1和idh2抑制剂及其应用 |
| WO2023134686A1 (zh) * | 2022-01-11 | 2023-07-20 | 正大天晴药业集团股份有限公司 | 一种1,3,5-三嗪衍生物的制备方法 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4713330A1 (en) | Tricyclic compounds and uses thereof | |
| WO2023280136A1 (zh) | 氘甲基取代吡嗪并吡嗪并喹啉酮类衍生物、其制备方法及其在医药上的应用 | |
| US12234211B2 (en) | Cycloolefin substituted heteroaromatic compounds and their use | |
| TW202142541A (zh) | 用作激酶抑制劑的化合物及其應用 | |
| CN120225530A (zh) | 异双官能化合物及治疗疾病的方法 | |
| CN111171020A (zh) | 一类六元并六元杂环化合物及其作为蛋白受体激酶抑制剂的用途 | |
| KR20240167844A (ko) | 질소 함유 헤테로시클릭 화합물, 이의 제조 방법 및 이의 의학적 응용 | |
| WO2023046030A1 (zh) | 一种egfr小分子抑制剂、含其的药物组合物及其用途 | |
| HK40098874A (en) | Cycloolefin substituted heteroaromatic compounds and their use | |
| HK40096142A (en) | Cycloolefin substituted heteroaromatic compounds and their use | |
| HK40097382A (en) | Cycloolefin substituted heteroaromatic compounds and their use | |
| HK40109090A (en) | Cycloolefin substituted heteroaromatic compounds and their use | |
| HK40027076A (en) | Cycloolefin substituted heteroaromatic compounds and their use | |
| HK40027076B (en) | Cycloolefin substituted heteroaromatic compounds and their use | |
| US20250320222A1 (en) | Tricyclic compounds and uses thereof | |
| WO2026026840A1 (en) | Tricyclic compounds and uses thereof | |
| NZ762447B2 (en) | Cycloolefin substituted heteroaromatic compounds and their use | |
| BR112020004563B1 (pt) | Compostos heteroaromáticos substituídos por ciclo-olefina e seu uso |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190315 |
|
| WD01 | Invention patent application deemed withdrawn after publication |